Latest Breaking News On - Traci mccarty - Page 13 : vimarsana.com

First Gene Therapy for Adults with Severe Hemophilia A, BioMarin s ROCTAVIAN™ (valoctocogene roxaparvovec), Approved by European Commission (EC)

/PRNewswire/ BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that the European Commission (EC) has granted conditional marketing authorization.

Nordrhein westfalenUnited statesJohannes oldenburgDebra charlesworthJean jacques bienaimTraci mccartyUniversity clinic in bonnEuropean commissionBiomarin pharmaceutical incHaemophilia centreReplay international numberExchange commissionInternational numberPrnewswire biomarin pharmaceutical incEuropean medicines agencyRobust clinical program

First Gene Therapy for Adults with Severe Hemophilia A, BioMarin s ROCTAVIAN™ (valoctocogene roxaparvovec), Approved by European Commission (EC)

/PRNewswire/ BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that the European Commission (EC) has granted conditional marketing authorization.

Nordrhein westfalenUnited statesJohannes oldenburgDebra charlesworthJean jacques bienaimTraci mccartyUniversity clinic in bonnEuropean commissionBiomarin pharmaceutical incHaemophilia centreReplay international numberExchange commissionInternational numberPrnewswire biomarin pharmaceutical incEuropean medicines agencyRobust clinical program

BioMarin Announces Record Revenues in Second Quarter 2022; Increases Full-year 2022 Top and Bottom-line Guidance

VOXZOGO™ $34 Million Contribution Drives Total Revenues of $534 Million in the Quarter; Total Revenues Grew 13% Year-Over-Year, Excluding Kuvan BioMarin.

United statesDebra charlesworthBiomarin aldurazymeTraci mccartyJean jacques bienaimEndocrine society annual meetingInternational society on thrombosisBiomarin pharmaceutical incReplay international numberCompany annual report on formBiomarin genzymeCommittee for medicinal products human useDrug administrationEuropean commissionDevelopment expenseExchange commission

BioMarin Announces Record Revenues in Second Quarter 2022; Increases Full-year 2022 Top and Bottom-line Guidance

BioMarin Announces Record Revenues in Second Quarter 2022; Increases Full-year 2022 Top and Bottom-line Guidance
businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDebra charlesworthBiomarin aldurazymeTraci mccartyJean jacques bienaimEndocrine society annual meetingInternational society on thrombosisBiomarin pharmaceutical incReplay international numberCompany annual report on formBiomarin genzymeCommittee for medicinal products human useDrug administrationEuropean commissionDevelopment expenseExchange commission

BioMarin to Host Second Quarter 2022 Financial Results Conference Call and Webcast on Wednesday, August 3, at 4:30pm ET

BioMarin to Host Second Quarter 2022 Financial Results Conference Call and Webcast on Wednesday, August 3, at 4:30pm ET
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Debra charlesworthTraci mccartyInternational replay numberBiomarin pharmaceutical incCanada replay dial in numberReplay dial in numberMarin pharmaceutical